EOC Pharma
Nanjing, United States· Est.
EOC Pharma develops novel oncology therapeutics targeting cancer signaling pathways.
Private Company
Total funding raised: $46.5M
About
EOC Pharma develops novel oncology therapeutics targeting cancer signaling pathways.
BiologicsSmall Molecules
Funding History
2Total raised:$46.5M
Series B$32M
Series A$14.5M